Literature DB >> 3580253

Excretion of chloroquine and desethylchloroquine in human milk.

F A Ogunbona, C O Onyeji, O O Bolaji, S E Torimiro.   

Abstract

The excretion of chloroquine and the major metabolite, desethylchloroquine, in breast milk was investigated in eleven lactating mothers following a single oral dose of chloroquine (600 mg base). The average milk to plasma concentration ratio at the 24th hour was 6.6 +/- 2.4 for chloroquine and 1.5 +/- 0.6 for desethylchloroquine in five of the volunteers. In five other volunteers the elimination half-life of chloroquine in milk was 8.8 +/- 4.7 days which was longer than that in saliva (3.9 +/- 1.0 days) from the same volunteers. The maximum daily dose of the drug that the infant can receive from breastfeeding was about 0.7% of the maternal start dose of the drug in malaria chemotherapy. It is, therefore, suggested that it is safe for mothers to breastfeed their infants when undergoing treatment for malaria with chloroquine.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3580253      PMCID: PMC1386098          DOI: 10.1111/j.1365-2125.1987.tb03078.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  10 in total

1.  Absorption of antimalarial drugs in human skin; spectroscopic and chemical analysis in epidermis and corium.

Authors:  B SHAFFER; M M CAHN; E J LEVY
Journal:  J Invest Dermatol       Date:  1958-06       Impact factor: 8.551

2.  STUDIES ON THE CHEMOTHERAPY OF THE HUMAN MALARIAS. VI. THE PHYSIOLOGICAL DISPOSITION, ANTIMALARIAL ACTIVITY, AND TOXICITY OF SEVERAL DERIVATIVES OF 4-AMINOQUINOLINE.

Authors:  R W Berliner; D P Earle; J V Taggart; C G Zubrod; W J Welch; N J Conan; E Bauman; S T Scudder; J A Shannon
Journal:  J Clin Invest       Date:  1948-05       Impact factor: 14.808

3.  Detection and distribution of chloroquine metabolites in human tissues.

Authors:  K KURODA
Journal:  J Pharmacol Exp Ther       Date:  1962-08       Impact factor: 4.030

4.  Liquid chromatographic analysis of chloroquine and desethylchloroquine in human plasma, saliva and urine.

Authors:  F A Ogunbona; C O Onyeji; A A Lawal; C M Chukwuani; O O Bolaji
Journal:  J Chromatogr       Date:  1986-08-02

Review 5.  Excretion of drugs in human milk.

Authors:  T E O'Brien
Journal:  Am J Hosp Pharm       Date:  1974-09

6.  Excretion of hydroxychloroquine in human milk.

Authors:  R L Nation; L P Hackett; L J Dusci; K F Ilett
Journal:  Br J Clin Pharmacol       Date:  1984-03       Impact factor: 4.335

Review 7.  Drug excretion in human breast milk: principles, pharmacokinetics and projected consequences.

Authors:  J T Wilson; R D Brown; D R Cherek; J W Dailey; B Hilman; P C Jobe; B R Manno; J E Manno; H M Redetzki; J J Stewart
Journal:  Clin Pharmacokinet       Date:  1980 Jan-Feb       Impact factor: 6.447

8.  Safety of chloroquine in chemosuppression of malaria during pregnancy.

Authors:  M S Wolfe; J F Cordero
Journal:  Br Med J (Clin Res Ed)       Date:  1985-05-18

Review 9.  Pharmacologic considerations of drug use in the lactating mother.

Authors:  C M Berlin
Journal:  Obstet Gynecol       Date:  1981-11       Impact factor: 7.661

10.  Saliva secretion of chloroquine in man.

Authors:  F A Ogubona; A A Lawal; C O Onyeji
Journal:  J Pharm Pharmacol       Date:  1986-07       Impact factor: 3.765

  10 in total
  9 in total

1.  Time-dependent variability of chloroquine secretion into human saliva.

Authors:  C O Onyeji; F A Ogunbona
Journal:  Pharm World Sci       Date:  1996-12

Review 2.  Clinical pharmacokinetics and metabolism of chloroquine. Focus on recent advancements.

Authors:  J Ducharme; R Farinotti
Journal:  Clin Pharmacokinet       Date:  1996-10       Impact factor: 6.447

Review 3.  Pharmacokinetics of quinine, chloroquine and amodiaquine. Clinical implications.

Authors:  S Krishna; N J White
Journal:  Clin Pharmacokinet       Date:  1996-04       Impact factor: 6.447

4.  Transfer of chloroquine and desethylchloroquine across the placenta and into milk in Melanesian mothers.

Authors:  Irwin Law; Kenneth F Ilett; L Peter Hackett; Madhu Page-Sharp; Francesca Baiwog; Servina Gomorrai; Ivo Mueller; Harin A Karunajeewa; Timothy M E Davis
Journal:  Br J Clin Pharmacol       Date:  2008-02-15       Impact factor: 4.335

Review 5.  Antimalarial drug toxicity: a review.

Authors:  W Robert J Taylor; Nicholas J White
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

Review 6.  Drugs in human milk. Clinical pharmacokinetic considerations.

Authors:  H C Atkinson; E J Begg; B A Darlow
Journal:  Clin Pharmacokinet       Date:  1988-04       Impact factor: 6.447

Review 7.  Principles of drug biodisposition in the neonate. A critical evaluation of the pharmacokinetic-pharmacodynamic interface (Part I).

Authors:  J B Besunder; M D Reed; J L Blumer
Journal:  Clin Pharmacokinet       Date:  1988-04       Impact factor: 6.447

Review 8.  Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases.

Authors:  K D Rainsford; Ann L Parke; Matthew Clifford-Rashotte; W F Kean
Journal:  Inflammopharmacology       Date:  2015-08-06       Impact factor: 5.093

Review 9.  Pharmacokinetics and Pharmacological Properties of Chloroquine and Hydroxychloroquine in the Context of COVID-19 Infection.

Authors:  Melanie R Nicol; Abhay Joshi; Matthew L Rizk; Philip E Sabato; Radojka M Savic; David Wesche; Jenny H Zheng; Jack Cook
Journal:  Clin Pharmacol Ther       Date:  2020-09-01       Impact factor: 6.903

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.